Skip to content

Specimen Stability Study

Urine Sample Processing Study:Analysis of Fresh Versus Frozen Urine Samples From Critically Ill Subjects

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01846884
Enrollment
124
Registered
2013-05-06
Start date
2012-11-30
Completion date
2013-05-31
Last updated
2013-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injury

Brief summary

To collect and process urine samples from critically ill subjects for use in assessing the effects of various urine sample freezing and storage conditions on biomarker test results.

Interventions

None listed

Sponsors

Astute Medical, Inc.
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
21 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Males and females 21 years of age or older 2. Subjects must be enrolled (first study-specific sample collection) within 24 hours of ICU admission * Subjects enrolled from ED or Floor must be admitted to the ICU within 24 hours of enrollment * Subjects enrolled in the ICU must have been admitted to the ICU or transferred into the study ICU from another ICU no more than 24 hours prior to enrollment 3. Expected to remain in the ICU for at least 48 hours after enrollment 4. Use of indwelling urinary catheter as standard care expected for at least 48 hours after enrollment 5. Subject (or authorized representative)able and willing to provide written informed consent for study participation

Exclusion criteria

1. Special populations including children, pregnant women, and prisoners 2. Previous renal transplantation 3. Already receiving dialysis (either acute or chronic) or in imminent need of dialysis at the time of enrollment 4. Known infection with human immunodeficiency virus (HIV) or active hepatitis (acute or chronic) 5. Subjects with a history of chronic kidney disease (CKD) without a baseline serum creatinine value (baseline within 6 months of enrollment) 6. Previously provided a urine sample and enrolled in this study

Design outcomes

Primary

MeasureTime frame
Specimen handling and stability, for example, effect of temperature on biomarker results. There are no primary clinical outcomes.6 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026